Table 1.
Clinical characteristics of all patients with CRC, CA and NC.
Factors | CRC (n=40) |
CA (n=22) |
NC (n=52) |
---|---|---|---|
Age, n (%) | |||
<55 years | 4 (10.0) | 6 (27.3) | 22 (42.3) |
≥55 years | 36 (90.0) | 16 (72.7) | 30 (57.7) |
Gender, n (%) | |||
Male | 30 (75.0) | 18 (81.8) | 36 (69.2) |
Female | 10 (25.0) | 4 (18.2) | 16 (30.8) |
Tumor size, n (%) | |||
<2cm | 11 (27.5) | 12 (54.5) | / |
≥2cm | 26 (65.0) | 10 (45.5) | / |
NA | 3 (7.5) | 0 (0.0) | / |
Invasive depth | |||
Mucosa | 14 (35.0) | 22 (100.0) | / |
Submucosa | 25 (62.5) | 0 (0.0) | / |
NA | 1 (2.5) | 0 (0.0) | / |
Clinical stage, n (%) | |||
I | 22 (55.0) | / | / |
II | 9 (22.5) | / | / |
III | 6 (15.0) | / | / |
NA | 3 (7.5) | / | / |
Lymph node metastasis, n (%) | |||
N | 32 (80.0) | / | / |
Y | 7 (17.5) | / | / |
NA | 1 (2.5) | / | / |
Location | |||
Right colon | 7 (17.5) | 4 (18.2) | / |
Left colon | 19 (47.5) | 9 (40.9) | / |
Rectum | 13 (32.5) | 6 (27.3) | / |
NA | 1 (2.5) | 3 (13.6) | / |
Yamada subtype, n (%) | |||
I | 5 (12.5) | 6 (27.3) | / |
II | 8 (20.0) | 8 (36.3) | / |
III | 4 (10.0) | 4 (18.2) | / |
IV | 2 (5.0) | 4 (18.2) | / |
NA | 21 (52.5) | 0 (0.0) | / |
Paris subtype, n (%) | |||
Is | 7 (17.5) | 7 (31.8) | / |
Ip | 3 (7.5) | 6 (27.3) | / |
Isp | 8 (20.0) | 7 (31.8) | / |
II | 1 (2.5) | 2 (9.1) | / |
NA | 21 (52.5) | 0 (0.0) | / |
Tumor differentiation status, n (%) | |||
CA-L | / | 3 (13.6) | / |
CA-H | / | 16 (72.8) | / |
SSA/NA | / | 3 (13.6) | / |
Clinical diagnosis, n (%) | |||
Gastritis | / | / | 28 (53.8) |
Cholelithiasis | / | / | 4 (7.7) |
PHT | / | / | 4 (7.7) |
Polyps | / | / | 6 (11.6) |
Others | / | / | 10 (19.2) |
CRC, Colorectal cancer; CA, colorectal adenoma; NC, non-cancerous lesion; CA-L, CA with low-grade intraepithelial neoplasia; CA-H, CA with high-grade intraepithelial neoplasia; NA, not available; SSA, sessile serrated adenoma; PHT, portal hypertension.